These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

440 related articles for article (PubMed ID: 23577497)

  • 1. Clinical challenges and unmet needs in the management of complicated intra-abdominal infections.
    Mazuski JE
    Surg Infect (Larchmt); 2005; 6 Suppl 2():S-49-69. PubMed ID: 23577497
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Role of moxifloxacin for the treatment of community-acquired [corrected] complicated intra-abdominal infections in Taiwan.
    Lau YJ; Chen YH; Huang CT; Lee WS; Liu CY; Liu JW; Liu HD; Lee YJ; Chen CW; Ko WC; Hsueh PR
    J Microbiol Immunol Infect; 2012 Feb; 45(1):1-6. PubMed ID: 22244019
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Therapy of 1,025 severely ill patients with complicated infections in a German multicenter study: safety profile and efficacy of tigecycline in different treatment modalities.
    Bodmann KF; Heizmann WR; von Eiff C; Petrik C; Löschmann PA; Eckmann C
    Chemotherapy; 2012; 58(4):282-94. PubMed ID: 23052187
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Inadequate Source Control and Inappropriate Antibiotics are Key Determinants of Mortality in Patients with Intra-Abdominal Sepsis and Associated Bacteremia.
    Tellor B; Skrupky LP; Symons W; High E; Micek ST; Mazuski JE
    Surg Infect (Larchmt); 2015 Dec; 16(6):785-93. PubMed ID: 26258265
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Antimicrobial de-escalation strategies in hospitalized patients with pneumonia, intra-abdominal infections, and bacteremia.
    Kaye KS
    J Hosp Med; 2012; 7 Suppl 1():S13-21. PubMed ID: 23737333
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Duration and cessation of antimicrobial treatment.
    File TM
    J Hosp Med; 2012; 7 Suppl 1():S22-33. PubMed ID: 23677632
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Antimicrobial de-escalation strategies in hospitalized patients with pneumonia, intra-abdominal infections, and bacteremia.
    Kaye KS
    J Hosp Med; 2012; 7 Suppl 1():S13-21. PubMed ID: 23677630
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Efficacy of tigecycline for the treatment of complicated intra-abdominal infections in real-life clinical practice from five European observational studies.
    Eckmann C; Montravers P; Bassetti M; Bodmann KF; Heizmann WR; Sánchez García M; Guirao X; Capparella MR; Simoneau D; Dupont H
    J Antimicrob Chemother; 2013 Jul; 68 Suppl 2():ii25-35. PubMed ID: 23772043
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Duration of Antimicrobial Therapy in Treating Complicated Intra-Abdominal Infections: A Comprehensive Review.
    Sartelli M; Catena F; Ansaloni L; Coccolini F; Di Saverio S; Griffiths EA
    Surg Infect (Larchmt); 2016 Feb; 17(1):9-12. PubMed ID: 26468904
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Current strategies for the treatment of complicated intraabdominal infections.
    Skrupky LP; Tellor BR; Mazuski JE
    Expert Opin Pharmacother; 2013 Oct; 14(14):1933-47. PubMed ID: 23876130
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Antimicrobial susceptibility of pathogens isolated from patients with complicated intra-abdominal infections at five medical centers in Taiwan that continuously participated in the Study for Monitoring Antimicrobial Resistance Trends (SMART) from 2006 to 2010.
    Lee YL; Chen YS; Toh HS; Huang CC; Liu YM; Ho CM; Lu PL; Ko WC; Chen YH; Wang JH; Tang HJ; Yu KW; Liu YC; Chuang YC; Liu CE; Hsueh PR
    Int J Antimicrob Agents; 2012 Jun; 40 Suppl():S29-36. PubMed ID: 22749056
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinical efficacy and correlation of clinical outcomes with in vitro susceptibility for anaerobic bacteria in patients with complicated intra-abdominal infections treated with moxifloxacin.
    Goldstein EJ; Solomkin JS; Citron DM; Alder JD
    Clin Infect Dis; 2011 Dec; 53(11):1074-80. PubMed ID: 21998288
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The empiric treatment of nosocomial intra-abdominal infections.
    Dupont H
    Int J Infect Dis; 2007 May; 11 Suppl 1():S1-6. PubMed ID: 17603948
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Postoperative bacterial/fungal infections: a challenging problem in critically ill patients after abdominal surgery.
    Lichtenstern C; Schmidt J; Knaebel HP; Martin E; Büchler MW; Weigand MA
    Dig Surg; 2007; 24(1):1-11. PubMed ID: 17259712
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Review of the guidelines for complicated skin and soft tissue infections and intra-abdominal infections--are they applicable today?
    Caínzos M
    Clin Microbiol Infect; 2008 Dec; 14 Suppl 6():9-18. PubMed ID: 19040462
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical challenges and unmet needs in the management of complicated skin and skin structure, and soft tissue infections.
    Turina M; Cheadle WG
    Surg Infect (Larchmt); 2005; 6 Suppl 2():S-23-36. PubMed ID: 23577495
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Patients with Complicated Intra-Abdominal Infection Presenting with Sepsis Do Not Require Longer Duration of Antimicrobial Therapy.
    Rattan R; Allen CJ; Sawyer RG; Askari R; Banton KL; Claridge JA; Cocanour CS; Coimbra R; Cook CH; Cuschieri J; Dellinger EP; Duane TM; Evans HL; Lipsett PA; Mazuski JE; Miller PR; O'Neill PJ; Rotstein OD; Namias N
    J Am Coll Surg; 2016 Apr; 222(4):440-6. PubMed ID: 26920994
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Risk factors for mortality and impact of broad-spectrum cephalosporin resistance on outcome in bacteraemic intra-abdominal infections caused by Gram-negative bacilli.
    Kang CI; Chung DR; Ko KS; Peck KR; Song JH;
    Scand J Infect Dis; 2011 Mar; 43(3):202-8. PubMed ID: 21142623
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Emerging issues in the diagnosis and management of infections caused by multi-drug-resistant, gram-positive cocci.
    Napolitano LM
    Surg Infect (Larchmt); 2005; 6 Suppl 2():S-5-22. PubMed ID: 23577494
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Safety and tolerability of tigecycline for the treatment of complicated skin and soft-tissue and intra-abdominal infections: an analysis based on five European observational studies.
    Guirao X; Sánchez García M; Bassetti M; Bodmann KF; Dupont H; Montravers P; Heizmann WR; Capparella MR; Simoneau D; Eckmann C
    J Antimicrob Chemother; 2013 Jul; 68 Suppl 2():ii37-44. PubMed ID: 23772045
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 22.